LGM Pharma’s Expanded Contract Development and Manufacturing Organization (CDMO) Capabilities Will Enable Customers to Accelerate and Optimize the New Product Pathway from Early Development Through ...
ROME, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Angelini Pharma, part of the privately owned Angelini Industries, and Sovargen, a South-Korean biotechnology company, announced today that they signed an ...
The new Emerson DeltaV PKM library reportedly cuts months from drug development by providing pre-built specification elements ...
Ascentage Pharma Group International ( ($HK:6855) ) just unveiled an update. Ascentage Pharma Group International has announced the current ...
Partnerships in healthcare have never been more important. Through collaboration, industry specialists are increasingly bringing cutting-edge medical innovations and life-changing treatments to ...
Silo Pharma, Inc., a biopharmaceutical company focused on developing innovative treatments for mental health and chronic pain, announced in a recent letter to shareholders that it expects to submit an ...
Royalty Pharma plc has completed a transaction to monetize remaining fixed payments on the MorphoSys Development Funding Bonds for $511 million in cash, resulting in total proceeds of $530 million ...
Phase 3 Development Program of Novel Selective Estrogen Receptor Modulator (SERM) Represents Potential Multi-Billion Dollar ...
Turbiscan technology accelerates lipid nanoparticle stability testing and supports robust pharmaceutical formulation ...
Sterling Pharma Solutions will spend $13 million to add process development labs and commercial-scale manufacturing equipment for pharmaceutical chemicals at its site in Dudley, England. The project ...
Donna Conroy, MS is Founder/CEO of SciMar ONE, Inc. a technology company building AI-based SaaS solutions for the pharmaceutical industry. Investing time and resources is clearly a long-term strategy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback